SSRIs, SNRIs and HRV: How Antidepressants Change Your Heart Rate Variability

Do SSRIs and SNRIs lower HRV?

If you track heart rate variability and you also take an antidepressant, you have probably wondered whether the medication is quietly dragging your numbers down. It is a fair question, and the honest answer is more reassuring than the scary version you may have read: for SSRIs and SNRIs, the effect on HRV is usually modest and mixed, not a clean collapse.

The confusion starts because two things are tangled together. Depression and anxiety themselves lower heart rate variability, before any pill is involved. So when you compare “people on antidepressants” to “healthy controls,” you are partly measuring the condition being treated, not the drug. Large reviews make exactly this point. In their review and meta-analysis of depression and HRV (Kemp et al., 2010), depression was associated with reduced HRV, and antidepressant treatment did not simply restore it even as mood symptoms improved. A broader analysis across psychiatric disorders (Alvares et al., 2016) found reduced HRV across the board, with medication effects that varied a lot by drug class.

So “antidepressants lower HRV” is true in a narrow, averaged sense, and misleading as a personal prediction. The class matters, the dose matters, and the condition you are treating matters. This article is educational field notes, not medical advice, and nothing here is a reason to change a prescription on your own.

The class matters more than the category

“Antidepressant” covers several drug families that act on the heart in different ways. Lumping them together is where most of the internet anxiety comes from.

Here is the short version of why each family behaves the way it does.

Tricyclics (amitriptyline, nortriptyline, imipramine). These are the class with the clearest HRV-lowering effect, and it is worth understanding even if you do not take one, because it anchors the scale. Tricyclics block acetylcholine, which is the exact chemical messenger the vagus nerve uses to slow the heart beat to beat. Blunt that signal and the beat-to-beat variability shrinks. Both meta-analyses above single out tricyclics as the strongest suppressor of HRV.

SNRIs (venlafaxine, desvenlafaxine, duloxetine). These raise both serotonin and noradrenaline. The noradrenaline part is the one that shows up on your watch or strap: SNRIs can nudge resting heart rate and blood pressure up, sometimes clearly at higher doses of venlafaxine. A higher heart rate mechanically compresses the intervals between beats, and a more sympathetically driven heart is a less variable one, so HRV can dip while your resting pulse rises.

SSRIs (sertraline, escitalopram, citalopram, fluoxetine, paroxetine). This is the gentlest group for HRV, and the research is genuinely mixed, with many studies showing little change. The one internal exception is paroxetine, which has more anticholinergic activity than its siblings and so behaves a touch more like a tricyclic. Sertraline and escitalopram tend to be the easiest on HRV.

Why the underlying condition muddies the reading

This is the part that gets lost. If anxiety or depression lowers your HRV, and a medication treats that anxiety or depression, then over time the medication could raise your HRV by easing the thing that was suppressing it. That is the opposite of the “pills lower HRV” story, and it is a real possibility for many people.

What the research suggests is that the timeline is slow and the picture is individual. The drug’s direct effect on the heart (small for most SSRIs, a bit more for SNRIs because of heart rate) can show up within days. The indirect benefit, a calmer nervous system as symptoms lift, unfolds over weeks to months and is the trend worth watching. Kemp and colleagues noted that treatment did not reliably normalize HRV in their pooled data, which is a caution against expecting a dramatic rebound, but it does not rule out a gradual climb as you stabilize.

The practical upshot: a single reading after you start a medication tells you almost nothing. The shape of your trend over the following months, read against how you actually feel, tells you a lot.

What changes, and what to compare it to

Here is a reference table for the metrics people watch most, and how an SSRI or SNRI can touch each.

None of these is a verdict on its own. The single most useful habit is to stop comparing readings across a medication change, and start a fresh baseline instead. Heart rate variability is a relative signal: it only means something against your own recent history, taken the same way. A dose change is a new “same way.”

SSRIs, SNRIs and POTS: the extra wrinkle

If you landed here because you have POTS or another form of dysautonomia, there is a second layer. Some SSRIs and SNRIs are used off-label to help POTS, acting in the brain to improve orthostatic tolerance and blunt the symptom load rather than working on the heart directly. For some people that helps meaningfully.

The catch is the same noradrenaline effect that makes SNRIs raise heart rate. In hyperadrenergic POTS, where the problem is already too much sympathetic drive and high standing noradrenaline, an SNRI can be the wrong direction and may worsen symptoms, while in other POTS subtypes it is tolerated or helpful. This is exactly why “does this medication help POTS” is not a question an HRV number can answer. It is an individual call made with your clinician, informed by your symptoms, your blood pressure and your stand test, not by a single RMSSD value.

What tracking can do is give that conversation better evidence: a clean before-and-after around a medication change, read as two baselines, is far more useful to a clinician than a vague sense that you feel different.

How to read your data honestly on an antidepressant

A short checklist, the same discipline that applies to beta blockers and any other medication that touches the heart:

• Reset your baseline at every start or dose change. Do not compare this week’s readings to the ones before the change. Begin a new window.
• Measure consistently. Same time of day, same posture, same length, same relationship to your dose. If you take your medication at night, that is fine, just keep it constant. Our guide to building and using an HRV baseline covers the mechanics.
• Watch weeks, not mornings. HRV is noisy day to day. A single low reading after starting a medication is almost always noise, not the drug.
• Track resting heart rate and blood pressure too, especially on an SNRI. A sustained rise is the clearest signal worth raising with your clinician.
• Separate the drug from the condition. If your HRV climbs over two or three months as your mood or anxiety settles, that is plausibly the treatment working through the nervous system, not in spite of it.
• Never stop a medication for a cleaner number. Abrupt discontinuation of SSRIs and SNRIs can cause real discontinuation symptoms, which are especially common with short-half-life drugs like paroxetine and venlafaxine.

If you are also sorting out whether your symptoms are anxiety, a cardiovascular pattern, or both, our piece on POTS versus anxiety and the broader cortisol and HRV article are useful companions, since stress physiology sits underneath all of this.

The bottom line

SSRIs and SNRIs do not wreck your heart rate variability. Their direct effect is usually small, the old tricyclics are the class that clearly lowers HRV, SNRIs can raise your heart rate through noradrenaline, and the depression or anxiety being treated was lowering your HRV before any medication started. Treat a dose change as a fresh baseline, watch the multi-week trend alongside how you feel, and bring a clean before-and-after to your clinician rather than reacting to one morning’s reading. This is general education and not medical advice, so discuss any change to your treatment with the person who prescribed it.